Delivery Order SPE2DB20D2014-SPE2DB25FC86H
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 20, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is a firm fixed-price delivery order with a ceiling value of $3,684.34 and an ultimate completion date of May 21, 2025. This award was not set-aside and was competitively awarded, reflecting the vendor's capability to meet federal procurement requirements. The delivery is...
- The Defense Logistics Agency awarded a delivery order valued at $3,684.34 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This firm fixed-price contract, awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a non-set-aside competitive procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Abilify Maintena ER 400 mg vials with a ceiling value of $1,843.01. This is a firm fixed-price delivery order with an ultimate completion date of September 18, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,438.27 for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of August 28, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters operates. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,531.06 delivery order to AmerisourceBergen Drug Corp for Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 12, 2025. This is a firm fixed price contract with no set-aside designation, awarded on a competitive basis. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $3,785.30 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. This non-set-aside contract was awarded on September 9, 2025, with an ultimate completion date of September 10, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 300 mg syringes under a firm fixed-price contract valued at $3,147.13. The award, made on September 25, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of September 26, 2025. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $4,992.00 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of September 9, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $2,681.49 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes, with an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,842.17 to AmerisourceBergen Drug Corp for the supply of Abilify Maintena ER 400 mg syringes. The contract, awarded on May 5, 2025, with a completion date of May 6, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC86HDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $24,305.05 by the Defense Logistics Agency on August 28, 2025, for the supply of Abilify Maintena ER 400 mg syringes. The contract is firm fixed price with an ultimate completion date of August 29, 2025, and represents a competitive award with no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply comprehensive pharmaceutical and medical products to support military healthcare programs globally. As a critical vendor within the Defense Logistics Agency's pharmaceutical supply chain, AmerisourceBergen fulfills federal medical procurement needs for military and veteran healthcare systems through a diverse portfolio spanning brand-name medications, generics, vaccines, and specialized medical supplies. The parent IDC with DLA Troop Support Medical demonstrates the contractor's significant role in supporting Defense Health Agency operations and other federal healthcare systems. This delivery order for Abilify Maintena—an atypical antipsychotic used in psychiatric treatment—exemplifies the company's ongoing pharmaceutical supply capabilities under the broader global procurement vehicle that the DLA has structured to ensure reliable access to critical medications across military medical facilities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.3k | 8/28/25 |